What are the characteristics of an international biotech company? : a study of four drug discovery companies in the Turku area by Arve, Minna
  ABSTRACT  
   X   Master´s thesis 
   Licentiate´s thesis 




Subject International Business Date 26.05.2004 
Student number  
Author(s) Minna Arve 
Number of pages 139 
Title What are the characteristics of an international biotech company? - A study of four drug discovery companies in the Turku area. 
Supervi-
sor(s) 
Ph. D. Sten-Olof Hansén 




An important area of the pharmaceutical industry is the biotechnology industry. Because of the 
enormous R&D costs, risks in developing new drugs are very high. The new drug discovery com-
panies are currently in a difficult position. They are trying to survive financial ‘death valley’ by ob-
taining more capital in order to bring their clinical trials to a stage where their promising results 
could be sold or licensed. If they succeed with this, they will become important players within the 
pharmaceutical industry and fulfil the expectations what have been laid upon them. 
The purpose of this study is to find out what are the international characteristics of biotech com-
panies and how are these characteristics reflected in the drug development process. The first sub-
question focuses on the founder of the firm and the second sub-question focuses on the company 
itself. Theoretical framework of the study is based on the literature of Born Globals, entrepreneur’s 
personal factors, and organisational capability; organisation structure, human resources, and fi-
nance. The research approach is qualitative. The study is conducted as a case study; findings of this 
study are based on data of four drug discovery companies in the Turku area. Data was collected 
through individual interviews.  
The interviewees were asked about their past experience, personal networks and global mindset. 
Past experience was found to consist of high education, international experience, previous work ex-
perience within the pharmaceutical industry, scientific credibility, managerial experience, and good 
skills in English. Networks consist of colleagues, other companies, PharmaCluster members, other 
scientists and researchers in the field. Global mindset is about international attitude, proactiveness, 
openness, cultural acceptance, risk taking, innovativeness, and the ability to communicate and col-
laborate with other cultures. 
The interviewees were also asked about the organisational capacity of their company. All these 
companies have a matrix organisation and the company aims to function as a virtual corporation. In 
addition, two of the companies have gone through mergers and two of them have already licensing 
contracts. These companies need talented and skilful personnel as well as talented managers. Their 
financing comes mainly through Tekes, Sitra, the Academy of Finland, institutional investors, pub-
lic and private venture capitalists, and one of them has succeeded with an IPO. These companies are 
Born Global companies. 
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